Skip to Content

Imperial Brands PLC IMB

Rating as of

Morningstar’s Analysis

Currency in GBX
Is it the right time to buy or sell?
Find out with Morningstar Premium
Is it the right time to buy or sell?
Find out with Morningstar Premium

1-Star Price


5-Star Price


Economic Moat


Capital Allocation


Lowering Tobacco Valuations by Mid-Single-Digit Amounts After FDA Announces Plan to Ban Menthol

Analyst Note

| Philip Gorham, CFA, FRM |

Altria's in line first-quarter results were overshadowed by the Food and Drug Administration's announcement that it is to seek a ban on menthol cigarettes. Although the risk of a menthol ban has been a long-term overhang and one of the ESG risks we have identified, we did not include it in our base-case assumptions because we felt the legal burden of proof for implementing a ban--which required the FDA to prove that a ban would be a net public health benefit--was fairly high. Following the FDA's announcement, however, we believe the probability of a ban has now increased because the FDA clearly believes it has met that burden of proof. We still believe a ban will take years to implement, and we are lowering our stage II growth rate assumptions for the cigarette makers with exposure to the menthol category in the U.S. We are lowering our fair value estimates of Altria to $52 per share from $54, of British American Tobacco to GBX 4,000 from 4,300, and of Imperial Brands to GBX 2,900 from GBX 3,000. We believe the tobacco group remains undervalued, and our picks remain Philip Morris International, whose exposure to the U.S. is limited to a revenue share of its market-leading reduced risk portfolio, and Imperial Brands, which trades at under 10 times forward earnings and pays a dividend yield of 9%.

Read Full Analysis

Company Profile

Business Description

Imperial Brands is the world's fourth-largest international tobacco company (excluding China National Tobacco) with total fiscal 2020 volume of 239 billion cigarettes sold in more than 160 countries. The firm holds a leading global position in the fine-cut tobacco and hand-rolling paper categories. Recent acquisitions in the United States make Imperial the third-largest manufacturer in that market. Through its acquisition of Altadis, the firm has a logistics platform in Western Europe.

121 Winterstoke Road
Bristol, BS3 2LL, United Kingdom
T +44 1179636636
Sector Consumer Defensive
Industry Tobacco
Most Recent Earnings
Fiscal Year End Sep 30, 2021
Stock Type
Employees 32,500